top of page

Landmark collaboration with largest pharmaceutical company

Collaboration announced at International Investment Summit, meeting the PM's ambitions to catalyse investment in the UK and proving the UK is open for business. 

The UKs life sciences sector will receive a £279 million boost, announced at the International Investment Summit.

The UK’s world-leading life sciences sector will receive a £279 million boost to tackle significant health challenges, with an intent expressed by Lilly, the world’s largest pharmaceutical company, to invest in the UK as part of a collaborative partnership with UK government, announced at the International Investment Summit on Monday 14 October.


Plans to form a new collaboration through a memorandum of understanding will see the pharmaceutical giant backing the UK’s brightest and best life sciences talent with the planned launch of the first ‘Lilly Gateway Labs’ innovation accelerator in Europe. This facility will support early-stage life sciences businesses to develop transformative medicines by providing lab space, mentorship and potential financial backing to rocket future growth in the sector.   


Other Science, engineering & technology news

bottom of page